Successful treatment of multidrug-resistant Escherichia coli bacteremia with tigecycline in an acute myeloid leukemia child

Turkish Journal of Pediatrics

Volumn 54, Issue 1, 2012, Pages 59-60

  Özdemir, Halil ^a   Çiftçi, Ergin ^a   Karbuz, Adem ^a   Oktay, Gülşah ^a   Aysev, Derya ^a   Yavuz, Gülsan ^a   Ince, Erdal ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

Child; Escherichia coli; Leukemia; Tigecycline

Indexed keywords

AMIKACIN; AMPHOTERICIN B LIPID COMPLEX; CEFEPIME; COLISTIN; MEROPENEM; TEICOPLANIN; TIGECYCLINE;

ABNORMAL LABORATORY RESULT; ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; BLOOD CELL COUNT; CANCER CHEMOTHERAPY; CASE REPORT; CHILD; CLINICAL FEATURE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; FEMALE; FEVER; HUMAN; PHYSICAL EXAMINATION; SCHOOL CHILD; TREATMENT OUTCOME;

ANTI-BACTERIAL AGENTS; BACTEREMIA; CHILD; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI INFECTIONS; FEMALE; HUMANS; LEUKEMIA, MYELOID, ACUTE; MINOCYCLINE;

EID: 84858848559     PISSN: 00414301     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Candel FJ, Calvo N, Head J, et al. A combination of tigecycline, colistin, and meropenem against multidrug-resistant Acinetobacter baumannii bacteremia in a renal transplant recipient: pharmacodynamic and microbiological aspects. Rev Esp Quimioter 2010; 23: 103-108.
2. Falagas ME, Metaxas EI. Tigecycline for the treatment of patients with community-acquired pneumonia requiring hospitalization. Expert Rev Anti Infect Ther 2009; 7: 913-923.
3. Doan TL, Fung HB, Mehta D, Riska PF. Tigecycline: a glycylcycline antimicrobial agent. Clin Ther 2006; 28: 1079-1106.
4. Dinleyici EC, Yargic ZA, Bor O, Kiremitci A, Durmaz G. Tigecycline treatment of multi-drug-resistant Corynebacterium jeikeium infection in a child with relapsing and refractory acute lymphoblastic leukemia. Pediatr Blood Cancer 2010; 55: 349-351.
5. Pankey GA, Steele RW. Tigecycline: a single antibiotic for polymicrobial infections. Pediatr Infect Dis J 2007; 26: 77-78.
6. Gardiner D, Dukart G, Cooper A, Babinchak T. Safety and efficacy of intravenous tigecycline in subjects with secondary bacteremia: pooled results from 8 phase III clinical trials. Clin Infect Dis 2010; 50: 229-238.
7. Jaspan HB, Brothers AW, Campbell AJ, et al. Multidrug-resistant Enterococcus faecium meningitis in a toddler: characterization of the organism and successful treatment with intraventricular daptomycin and intravenous tigecycline. Pediatr Infect Dis J 2010; 29: 379-381.